Clinical Trial Update: EGb761 in Maintaining Mental Clarity in Women Receiving Chemotherapy for Newly Diagnosed Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating EGb761 (Ginkgo biloba extract) for maintaining mental clarity in women receiving chemotherapy for newly diagnosed breast cancer; the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• EGb761 (Ginkgo biloba extract)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Breast Cancer, Neurotoxicity | Phase 3 | Status: COMPLETED | Results posted: 2015-04-15